HomeQNCX • NASDAQ
add
Quince Therapeutics Inc
Previous close
$2.02
Day range
$2.02 - $2.07
Year range
$0.51 - $2.45
Market cap
86.24M USD
Avg Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.55M | 40.24% |
Net income | -5.49M | -2.64% |
Net profit margin | — | — |
Earnings per share | -0.13 | — |
EBITDA | -8.46M | -38.83% |
Effective tax rate | -0.24% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 47.85M | -42.51% |
Total assets | 126.52M | 48.17% |
Total liabilities | 81.59M | 3,521.26% |
Total equity | 44.93M | — |
Shares outstanding | 42.97M | — |
Price to book | 1.92 | — |
Return on assets | -16.35% | — |
Return on capital | -35.13% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.49M | -2.64% |
Cash from operations | -7.26M | -50.68% |
Cash from investing | 7.10M | 95.46% |
Cash from financing | -5.00M | -50,100.00% |
Net change in cash | -5.22M | -412.28% |
Free cash flow | -9.98M | -226.64% |
About
Founded
2012
Headquarters
Website
Employees
32
